These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 3735665)
1. [Basic and clinical studies on cefotaxime]. Matsuoka T; Ota H; Takeda J; Takatani O Jpn J Antibiot; 1986 Mar; 39(3):726-32. PubMed ID: 3735665 [TBL] [Abstract][Full Text] [Related]
2. [Serum levels and sputum levels of cefmenoxime in respiratory tract infections]. Matsumoto Y; Ninomaru S; Koshobu T; Ishikawa J; Nakatani S; Sasaki T Jpn J Antibiot; 1985 Jun; 38(6):1638-42. PubMed ID: 3862881 [TBL] [Abstract][Full Text] [Related]
3. [Fundamental and clinical evaluation on ceftriaxone in the pediatric field]. Toyonaga Y; Kurosu Y; Uekusa T; Nakamura H; Sugita M; Okabe T; Kawamura K; Seo K; Takahashi T; Hori M Jpn J Antibiot; 1984 Nov; 37(11):2060-82. PubMed ID: 6098702 [TBL] [Abstract][Full Text] [Related]
4. [Study on cefotaxime in respiratory surgery: transfer to lung tissue and kinetics in serum]. Morita J; Hamaguchi N; Yoshizawa K; Niki S; Kondo K Jpn J Antibiot; 1989 Nov; 42(11):2406-11. PubMed ID: 2621782 [TBL] [Abstract][Full Text] [Related]
5. [Fundamental and clinical evaluation of ceftriaxone in the field of pediatrics]. Satoh Y; Iwata S; Akita H; Murai T; Hayano S; Oikawa T; Osano M Jpn J Antibiot; 1984 Nov; 37(11):2034-48. PubMed ID: 6098700 [TBL] [Abstract][Full Text] [Related]
6. [Fundamental and clinical evaluation of ceftriaxone in the pediatric field]. Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M Jpn J Antibiot; 1984 Nov; 37(11):2111-30. PubMed ID: 6098705 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic and clinical studies on cefodizime in the pediatric field. Pediatric Study Group of Cefodizime]. Fujii R; Arimasu O; Meguro H; Hiruma F; Sugie N; Abe T; Nakazawa S; Sato H; Narita A; Matsumoto K Jpn J Antibiot; 1989 May; 42(5):1173-93. PubMed ID: 2664256 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic and clinical studies of cefpirome in pediatric field]. Haruta T; Kuroki S; Okura K; Yamakawa M; Nigami H; Naramura M; Yoshida N; Kobayashi Y Jpn J Antibiot; 1991 Feb; 44(2):223-33. PubMed ID: 1828275 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation on ceftriaxone in the pediatric field]. Nakazawa S; Satoh H; Niino K; Hirama Y; Narita A; Suzuki H; Nakazawa S; Chikaoka H; Tazoe K Jpn J Antibiot; 1984 Nov; 37(11):2083-101. PubMed ID: 6098703 [TBL] [Abstract][Full Text] [Related]
10. [Clinical studies of ceftizoxime suppositories in respiratory tract infections and urinary tract infections in children]. Iwai N; Taneda Y; Shibata M; Mizoguchi F; Nakamura H; Katayama M Jpn J Antibiot; 1985 Oct; 38(10):2903-16. PubMed ID: 3866084 [TBL] [Abstract][Full Text] [Related]
11. [Basic and clinical studies of cefotiam in neonates and premature infants]. Iwata S; Sato Y; Kusumoto Y; Shiro H; Akita H; Nanri S; Oikawa T; Osano M; Sunakawa K Jpn J Antibiot; 1986 Sep; 39(9):2407-20. PubMed ID: 3540358 [TBL] [Abstract][Full Text] [Related]
12. [Clinical and pharmacokinetic evaluation of cefodizime in children]. Hirabayashi Y; Higashino H; Kino M; Nobori U; Okazaki H; Kitamura N; Kobayashi Y Jpn J Antibiot; 1989 Jun; 42(6):1366-80. PubMed ID: 2795860 [TBL] [Abstract][Full Text] [Related]
13. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kawaguchi H; Shimizu Y; Matsumiya H; Saito A; Terai T; Inoue H; Nakadate T; Ito C; Yosida T; Tanno Y; Ohno I; Nishioka K; Arakawa M; Igarashi K; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Touyama M Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366 [TBL] [Abstract][Full Text] [Related]
14. [Laboratory and clinical studies on ceftizoxime in the field of pediatrics (author's transl)]. Toyonaga Y; Kurosu Y; Sugita M; Kawamura G; Okuyama M; Yoshino N; Hori M; Takahashi T Jpn J Antibiot; 1982 Jan; 35(1):9-32. PubMed ID: 6279916 [TBL] [Abstract][Full Text] [Related]
15. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860 [TBL] [Abstract][Full Text] [Related]
16. [Clinical study on transfer into lung tissue and postoperative prophylactic effect of new cephamycin antibiotics, particularly cefotetan and cefbuperazone]. Imaizumi M; Niimi T; Uchida T; Kajita M; Takahashi T; Uchida Y; Asaoka M; Amano Y; Ojika T; Abe T Jpn J Antibiot; 1988 Apr; 41(4):437-59. PubMed ID: 3165475 [TBL] [Abstract][Full Text] [Related]
17. [Laboratory and clinical studies on SY5555 in pediatrics]. Iwai N; Nakamura H Jpn J Antibiot; 1995 Jan; 48(1):103-28. PubMed ID: 7699834 [TBL] [Abstract][Full Text] [Related]
18. [Fundamental and clinical studies on cefminox in the field of pediatrics]. Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M Jpn J Antibiot; 1985 Mar; 38(3):705-19. PubMed ID: 3897604 [TBL] [Abstract][Full Text] [Related]
19. [Fundamental and clinical studies on cefixime in pediatrics]. Iwai N; Shibata M; Mizoguchi F; Nakamura H; Katayama M Jpn J Antibiot; 1986 Apr; 39(4):1087-105. PubMed ID: 3761539 [TBL] [Abstract][Full Text] [Related]
20. [Fundamental and clinical studies on cefixime (5% granules) in the pediatric field]. Toyonaga Y; Sugita M; Nakamura H; Joh K; Takahashi T; Kurosu Y; Hori M Jpn J Antibiot; 1986 Apr; 39(4):1055-75. PubMed ID: 3761537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]